tirzepatide surpass trials Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism Tirzepatide for diabetes: on track

Microbiota depletion in HFD-fed mice elevates plasma GLP-1 levels and attenuates hypothalamic inflammation, actions that require the astrocyte GLP-1R (49)

Intestinal Obstructions Blockage of the small intestine and portions of the large intestine needs to be taken seriously

It's great to see the data back up what many have been theorizing for awhile

Ozempic Face is the gaunt, aged facial appearance caused by rapid facial fat loss during GLP-1 therapy

5 That pattern of regain is consistent across trials, particularly when people stop these medications suddenly before theyve built the habits needed to maintain their new weight

Andrea D